US drugmaker Moderna announced on Tuesday that it had submitted a request for an emergency use approval for its COVID-19 vaccine for children ages ranging between 6 months and 6 years.
Moderna’s Chief Executive, Stephane Bancel, said in a statement: “We believe [this vaccine] will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID -19 and will be especially welcomed by parents and caregivers.”
On the other hand, leading drug-makers Pfizer and BioNTech submitted a request to get the approval of the Food and Drug Authority (FDA) for booster shots for children between 5 and 11.
The request from the drug-makers came after a new study showed that the booster shots could give children strong immune response against COVID-19.
The booster dose will be given to children six months after receiving the essential doses.
It is worthy to mention that the US health authorities approved a second COVID-19 booster dose for two vaccines: Pfizer and Moderna, for people aged 50 and older last March.
The essential motive for issuing such a decision was raising the immune response of aged people against the Omicron variant risks.
Follow the latest news on Google News
